Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-31
2006-01-31
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S486000, C424S549000, C514S008100, C514S012200, C514S772500
Reexamination Certificate
active
06992066
ABSTRACT:
A liquid carrier medium is provided which is suitable for solubilizing growth factors, such as mixtures of bone morphogenetic proteins, that are found to induce an angiogenic response in ischemic tissues. The liquid medium comprises an aqueous solution of polyvinyl pyrrolidone.
REFERENCES:
patent: 3927205 (1975-12-01), Ohno et al.
patent: 4699788 (1987-10-01), Catsimpoolas et al.
patent: 4895838 (1990-01-01), McCluer et al.
patent: 4900673 (1990-02-01), Harper et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 5116738 (1992-05-01), Wang et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5187076 (1993-02-01), Wozney et al.
patent: 5219576 (1993-06-01), Chu et al.
patent: 5290763 (1994-03-01), Poser et al.
patent: 5318957 (1994-06-01), Cid et al.
patent: 5328695 (1994-07-01), Lucas et al.
patent: 5371191 (1994-12-01), Poser et al.
patent: 5459047 (1995-10-01), Wozney et al.
patent: 5470831 (1995-11-01), Whitman et al.
patent: 5543392 (1996-08-01), Tomita et al.
patent: 5543394 (1996-08-01), Wozney et al.
patent: 5595722 (1997-01-01), Grainger et al.
patent: 5616490 (1997-04-01), Sullivan et al.
patent: 5631142 (1997-05-01), Wang et al.
patent: 5635372 (1997-06-01), Celeste et al.
patent: 5637480 (1997-06-01), Celeste et al.
patent: 5656587 (1997-08-01), Sporn et al.
patent: 5661007 (1997-08-01), Wozney et al.
patent: 5677276 (1997-10-01), Dickerson et al.
patent: 5703043 (1997-12-01), Celeste et al.
patent: 5705477 (1998-01-01), Sporn et al.
patent: 5846770 (1998-12-01), LaVallie et al.
patent: 5849880 (1998-12-01), Wozney et al.
patent: 5854207 (1998-12-01), Lee et al.
patent: 5866364 (1999-02-01), Israel et al.
patent: 5928940 (1999-07-01), Sampath et al.
patent: 5932216 (1999-08-01), Celeste et al.
patent: 5965403 (1999-10-01), Celeste et al.
patent: 5972884 (1999-10-01), Cohen et al.
patent: 5981489 (1999-11-01), Stevenson et al.
patent: 5994094 (1999-11-01), Hötten et al.
patent: 6051648 (2000-04-01), Rhee et al.
patent: 6120760 (2000-09-01), Hötten et al.
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6150328 (2000-11-01), Wang et al.
patent: 6177406 (2001-01-01), Wang et al.
patent: 6197550 (2001-03-01), Hötten et al.
patent: 6211157 (2001-04-01), Benedict et al.
patent: 6468960 (2002-10-01), Lukanidin et al.
patent: 6498142 (2002-12-01), Sampath et al.
patent: 2002/0009789 (2002-01-01), Hanyu et al.
patent: 2002/0025340 (2002-02-01), Dyer
patent: 2002/0040004 (2002-04-01), Benedict et al.
patent: 2003/0104977 (2003-06-01), Ripamonti et al.
patent: 1163780 (1997-11-01), None
patent: 0433225 (1991-06-01), None
patent: 516901 (1992-12-01), None
patent: 0747066 (1996-12-01), None
patent: WO 97/41880 (1997-11-01), None
patent: WO 99/02674 (1999-01-01), None
patent: WO 99/31136 (1999-06-01), None
patent: WO 99/57146 (1999-11-01), None
patent: WO 02/00244 (2002-01-01), None
patent: WO 02/47713 (2002-06-01), None
Chemical Abstract 132:40522x (Jan. 24, 2000).
Mueller et al. Myocardial angiogenesis induction with bone protein derived growth factors (animal experiment). Swiss Medical Weekly. vol. 131, pp. 23-25 (Jan. 12, 2001).
Prochazka et al. Epidermal growth factor and insulin growth factor . . . Journal of Reproduction and fertility. No. 25, p. 64, Abstract No. 173 (Jul. 2000).
Sakaguchi et al. A Combination Of EGF and IGF-I Accelerates . . . Theriogenology. vol. 54, pp. 1327-1342 (2000).
Wiley et al. Epidermal Growth Factor Stimulates Fluid Phase Endocytosis . . . Journal of Cellular Biochemistry. vol. 19, pp. 383-394 (1982).
Wu et al. Percutaneous injection of bone morphogenetic protein and polyvinyl pyrrolidone composite . . . Journal Of Xi'An Medical University. vol. 22. No. 2, pp. 132-134 (Apr. 2001).
PCT International Search Report, PCT/US02/41077 dated Jul. 28, 2003.
Hu, Yunyu et al.,Injection of basic fibroblast growth factor and bone morphogenetic protein for osteogenesis stimulation, Chemical Abstracts 63 Pharmaceuticals, vol. 13, No. 4 (Jan. 24, 2000) 132: 40522. Faming Zhuanli Shenqing Gongkai Shuomingshu, CN 1,163,780 Nov. 5, 1997 (CH).
R.J. Laham et al.,Intrapericardial Delivery of Fibroblast Growth Factor -2 Indices Neovascularization in a Procine Model of Chronic Myocardial Ischemia, J. Pharmolocol. Exp. Ther. 292(2), 795-802 (2000).
N. Yamamoto et al.,Histological Evidence That Basic Fibroblast Growth Factor Enhances the Aniogenic Effect of Transmyocardial Laser Revascularization, J. Pharmocolo. Exp. Ther. 95(1), 55-63 (2000).
Robinson, Sullivan, Borzelleca, Schwartz,PVP: a Critical Review of the Kinetics and Toxicology of the Polyvinylpyrrolldone(Providone), Lewis Publisherss, Inc., Synthesis and Properties of PVP, pp. 10-19.
Yonggang, Chen Junchang et al.,Percutaneous injection of bone morphogenetic protein and polyvinyl pyrrolidone composite, Journal of XI'AN Medical University (Apr. 2001) vol. 22, No. 2 (English Abstract).
Cuevas et al., “Fibroblast Growth Factor Protects the Kidney Against Ischemia-Reperfusion Injury,”Eur. J. Med. Res., 4:403-10, 1999.
Folkman, “Angiogenic Therapy of the Human Heart,”Circulation, 97:628-29, 1998.
Freed et al., “Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers,”J. Biomed. Mater. Res., 27:11-23, 1993.
Freedman and Isner, “Therapeutic Angiogenesis for Ischemic Cardiovascular Disease,”J. Molecular and Cellular Cardiology, 33:379-93, 2001.
Hammerman, “Growth Factors in Renal Development,”Seminars in Nephrology, 15:291-99, 1995.
Hirschberg et al., “Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure,”Kidney International, 55:2423-32, 1999.
Kawa-uchi et al., “Fibroblast growth factor enhances expression of TGFβ-stimulated-clone-22 gene in osteoblast-like cells,”Endocrine, 3:833-37, 1995.
Nakaoka et al., “Inhibition of Rat Vascular Smooth Muscle Proliferation In Vitro and In Vivo by Bone Morphogenetic Protein-2,”J. Clin. Invest., 100:2824-32, 1997.
Nishida et al., “Adenovirus-Mediated Gene Transfer to Nucleus Pulposus Cells,”Spine, 23:2437-42, 1998.
Parsons-Wingerter et al., “A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection,”Microvasc. Res., 55:201-14, 1998.
Ramoshebi and Ripamonti, “Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta1,”Anta. Rec., 259:97-107, 2000.
Schumacher et al., “Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors,”Circulation, 97:645-50, 1998.
Stelnicki et al., “Bone Morphogenetic Protein-2 Induces Scar Formation and Skin Maturation in the Second Trimester Fetus,”Plastic and Reconstructive Surgery, 101:12-19, 1998.
Vukicevic et al., “Osteogenic Protein-1 (Bone Morphogenetic Protein-7) Reduces Severity of Injury After Ischemic Acute Renal Failure in Rat,”J. Clin. Invest., 102:202-14, 1998.
Yamashita et al., “Growth/Differentiation Factor-5 Induces Angiogenesis In Vivo,”Exper. Cell Res., 235:218-26, 1997.
Akella Rama
Ranieri John
Russel Jeffrey Edwin
Williams Morgan & Amerson P.C.
Zimmer Orthobiologics, Inc.
LandOfFree
Povidone-containing carriers for polypeptide growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Povidone-containing carriers for polypeptide growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Povidone-containing carriers for polypeptide growth factors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3526513